The Push for Value-Based Drug Prices Requires Electronic Health Record Interoperability

There has been a push towards value-based pricing (VBP) for prescription drugs, especially with new drug pricing reform in the US. Reaching this goal will require extensive data to determine the value of medications. An important resource is electronic health records (EHR), but these sources are rarely interoperable. In a new article on Healthcare IT Today, Girisha Fernando of Lyfegen discusses why data interoperability is so essential for VBP.

According to Fernando, “One important factor that is key to the growth and success of VBP – and making the transition to it smoother – is to expand the use of electronic health records (EHR). This provides a common system where all parties will have access to the health history of a patient, including their current and past treatments, the drugs they have been prescribed, and their outcomes – all key data components needed to make VBP work.”

To read more, click here.

(Source: Healthcare IT Today, October 10^th, 2022)